Article
Efficacy and safety of direct-acting antivirals-based antiviral therapies for hepatitis C virus patients with stage 4-5 chronic kidney disease: a meta-analysis.
Liver international : official journal of the International Association for the Study of the Liver - 1 Jul 2017
Li Tao, Qu Yundong, Guo Ying, Wang Yan, Wang Lei
Abstract excerpt
BACKGROUND & AIMS: The aim of this study was to assess the efficacy and safety of direct-acting antivirals (DAA)-based antiviral therapies for HCV patients with stage 4-5 chronic kidney disease. METHODS: We conducted a systematic literature search in PubMed, EMBASE, Web of Science, and CENTRAL on the Cochrane Library without time and language limitations. The search strategy used was "(End stage renal disease OR...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.